133 related articles for article (PubMed ID: 38888469)
61. The genomic landscape of fibrolamellar hepatocellular carcinoma: whole genome sequencing of ten patients.
Darcy DG; Chiaroni-Clarke R; Murphy JM; Honeyman JN; Bhanot U; LaQuaglia MP; Simon SM
Oncotarget; 2015 Jan; 6(2):755-70. PubMed ID: 25605237
[TBL] [Abstract][Full Text] [Related]
62. Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy.
Tanaka H; Hijioka S; Iwaya H; Mizuno N; Kuwahara T; Okuno N; Ito A; Kuraoka N; Matsumoto S; Obata M; Kurita Y; Yasuda M; Shimizu Y; Kuroda H; Sato Y; Haneda M; Sasaki E; Yatabe Y; Hara K
Intern Med; 2018 Dec; 57(24):3537-3543. PubMed ID: 30101933
[TBL] [Abstract][Full Text] [Related]
63. Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.
Singhi AD; Wood LD; Parks E; Torbenson MS; Felsenstein M; Hruban RH; Nikiforova MN; Wald AI; Kaya C; Nikiforov YE; Favazza L; He J; McGrath K; Fasanella KE; Brand RE; Lennon AM; Furlan A; Dasyam AK; Zureikat AH; Zeh HJ; Lee K; Bartlett DL; Slivka A
Gastroenterology; 2020 Feb; 158(3):573-582.e2. PubMed ID: 31678302
[TBL] [Abstract][Full Text] [Related]
64. PKA Cα subunit mutation triggers caspase-dependent RIIβ subunit degradation via Ser
Weigand I; Ronchi CL; Vanselow JT; Bathon K; Lenz K; Herterich S; Schlosser A; Kroiss M; Fassnacht M; Calebiro D; Sbiera S
Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33608270
[TBL] [Abstract][Full Text] [Related]
65. Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms.
Chan GKL; Maisel S; Hwang YC; Pascual BC; Wolber RRB; Vu P; Patra KC; Bouhaddou M; Kenerson HL; Lim HC; Long D; Yeung RS; Sethupathy P; Swaney DL; Krogan NJ; Turnham RE; Riehle KJ; Scott JD; Bardeesy N; Gordan JD
Elife; 2023 Jan; 12():. PubMed ID: 36692000
[TBL] [Abstract][Full Text] [Related]
66. Phase Separation of a PKA Regulatory Subunit Controls cAMP Compartmentation and Oncogenic Signaling.
Zhang JZ; Lu TW; Stolerman LM; Tenner B; Yang JR; Zhang JF; Falcke M; Rangamani P; Taylor SS; Mehta S; Zhang J
Cell; 2020 Sep; 182(6):1531-1544.e15. PubMed ID: 32846158
[TBL] [Abstract][Full Text] [Related]
67. A case report of fibrolamellar hepatocellular carcinoma, with particular reference to preoperative diagnosis, value of molecular genetic diagnosis, and cell origin.
Takahashi A; Imamura H; Ito R; Kawano F; Gyoda Y; Ichida H; Yoshioka R; Mise Y; Fukumura Y; Sano K; Saiura A
Surg Case Rep; 2021 Sep; 7(1):208. PubMed ID: 34533614
[TBL] [Abstract][Full Text] [Related]
68. Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome.
Beuschlein F; Fassnacht M; Assié G; Calebiro D; Stratakis CA; Osswald A; Ronchi CL; Wieland T; Sbiera S; Faucz FR; Schaak K; Schmittfull A; Schwarzmayr T; Barreau O; Vezzosi D; Rizk-Rabin M; Zabel U; Szarek E; Salpea P; Forlino A; Vetro A; Zuffardi O; Kisker C; Diener S; Meitinger T; Lohse MJ; Reincke M; Bertherat J; Strom TM; Allolio B
N Engl J Med; 2014 Mar; 370(11):1019-28. PubMed ID: 24571724
[TBL] [Abstract][Full Text] [Related]
69. An acquired scaffolding function of the DNAJ-PKAc fusion contributes to oncogenic signaling in fibrolamellar carcinoma.
Turnham RE; Smith FD; Kenerson HL; Omar MH; Golkowski M; Garcia I; Bauer R; Lau HT; Sullivan KM; Langeberg LK; Ong SE; Riehle KJ; Yeung RS; Scott JD
Elife; 2019 May; 8():. PubMed ID: 31063128
[TBL] [Abstract][Full Text] [Related]
70. Molecular Basis of Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma.
Surjan RCT; de Lima TM; de Souza HP; Machado MCC; Ardengh JC
Cureus; 2023 Jan; 15(1):e33750. PubMed ID: 36788919
[TBL] [Abstract][Full Text] [Related]
71. Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma.
Levin SN; Tomasini MD; Knox J; Shirani M; Shebl B; Requena D; Clark J; Heissel S; Alwaseem H; Surjan R; Lahasky R; Molina H; Torbenson MS; Lyons B; Migler RD; Coffino P; Simon SM
Sci Adv; 2023 Jun; 9(25):eadg7038. PubMed ID: 37343102
[TBL] [Abstract][Full Text] [Related]
72. Fibrolamellar hepatocellular carcinoma: a case report and gene analysis.
Watanabe A; Harimoto N; Saito H; Kawabata-Iwakawa R; Seki T; Muranushi R; Hoshino K; Hagiwara K; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Ikota H; Ishige T; Mimori K; Shirabe K
Surg Case Rep; 2023 Sep; 9(1):168. PubMed ID: 37728655
[TBL] [Abstract][Full Text] [Related]
73. Germline and Mosaic Variants in PRKACA and PRKACB Cause a Multiple Congenital Malformation Syndrome.
Palencia-Campos A; Aoto PC; Machal EMF; Rivera-Barahona A; Soto-Bielicka P; Bertinetti D; Baker B; Vu L; Piceci-Sparascio F; Torrente I; Boudin E; Peeters S; Van Hul W; Huber C; Bonneau D; Hildebrand MS; Coleman M; Bahlo M; Bennett MF; Schneider AL; Scheffer IE; Kibæk M; Kristiansen BS; Issa MY; Mehrez MI; Ismail S; Tenorio J; Li G; Skålhegg BS; Otaify GA; Temtamy S; Aglan M; Jønch AE; De Luca A; Mortier G; Cormier-Daire V; Ziegler A; Wallis M; Lapunzina P; Herberg FW; Taylor SS; Ruiz-Perez VL
Am J Hum Genet; 2020 Nov; 107(5):977-988. PubMed ID: 33058759
[TBL] [Abstract][Full Text] [Related]
74. Update on the pathology of liver neoplasms.
Matsukuma KE; Yeh MM
Ann Diagn Pathol; 2019 Feb; 38():126-137. PubMed ID: 30597357
[TBL] [Abstract][Full Text] [Related]
75. Somatic PRKACA Mutations: Association With Transition From Pituitary-Dependent to Adrenal-Dependent Cushing Syndrome.
Di Dalmazi G; Timmers HJLM; Arnaldi G; Küsters B; Scarpelli M; Bathon K; Calebiro D; Beuschlein F; Hermus A; Reincke M
J Clin Endocrinol Metab; 2019 Nov; 104(11):5651-5657. PubMed ID: 31276155
[TBL] [Abstract][Full Text] [Related]
76. Microinsertions in PRKACA cause activation of the protein kinase A pathway in cardiac myxoma.
Tseng IC; Huang WJ; Jhuang YL; Chang YY; Hsu HP; Jeng YM
J Pathol; 2017 Jun; 242(2):134-139. PubMed ID: 28369983
[TBL] [Abstract][Full Text] [Related]
77. Differential role of PKA catalytic subunits in mediating phenotypes caused by knockout of the Carney complex gene Prkar1a.
Yin Z; Pringle DR; Jones GN; Kelly KM; Kirschner LS
Mol Endocrinol; 2011 Oct; 25(10):1786-93. PubMed ID: 21852354
[TBL] [Abstract][Full Text] [Related]
78. Overexpression of olfactory receptor 78 ameliorates brain injury in cerebral ischaemia-reperfusion rats by activating Prkaca-mediated cAMP/PKA-MAPK pathway.
Kang T; Zhu L; Xue Y; Yang Q; Lei Q; Wang Q
J Cell Mol Med; 2024 Jun; 28(11):e18366. PubMed ID: 38856956
[TBL] [Abstract][Full Text] [Related]
79. Discovery and Synthesis of a Naturally Derived Protein Kinase Inhibitor that Selectively Inhibits Distinct Classes of Serine/Threonine Kinases.
Du L; Wilson BAP; Li N; Shah R; Dalilian M; Wang D; Smith EA; Wamiru A; Goncharova EI; Zhang P; O'Keefe BR
J Nat Prod; 2023 Oct; 86(10):2283-2293. PubMed ID: 37843072
[TBL] [Abstract][Full Text] [Related]
80. Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells.
Oikawa T; Wauthier E; Dinh TA; Selitsky SR; Reyna-Neyra A; Carpino G; Levine R; Cardinale V; Klimstra D; Gaudio E; Alvaro D; Carrasco N; Sethupathy P; Reid LM
Nat Commun; 2015 Oct; 6():8070. PubMed ID: 26437858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
